BioHealth News Archive
BARDA: The venture capital firm buried in the U.S. government – Marketplace.org
For five years, John Eldridge and his team at Profectus Bioscience have developed and tested their Ebola vaccine. First it was on guinea pigs, then…
Read More
When will digital health go mainstream? When millennials are older and sicker
I’m so used to hearing bullish projections on digital health, it’s refreshing when someone contradicts that assessment. Maybe contradict is the wrong word. But…
Read More
BioCrossroads: Life sciences funding hit $25B in past decade
In the decade after the founding of the BioCrossroads initiative, money spent on life sciences research and companies more than doubled, to more than…
Read More
A $1,000 Cancer Test – MIT Technology Review
The Hong Kong scientist who invented a simple blood test to show pregnant women if their babies have Down syndrome is now testing a…
Read More
Novavax sees ‘several billion-dollar global opportunity’ as it plans Ebola vaccine clinical trial by year-end – Washington Business Journal
Novavax Inc.'s singular drug development approach to a possible Ebola vaccine may not only help stop the spread of a future pandemic but also…
Read More
New York Medical College launches biotech incubator
New York Medical College will inaugurate its biotechnology incubator Wednesday. The multimillion-dollar BioInc@NYMC at 7 Dana Drive in Valhalla will offer space to scientists,…
Read More
Johns Hopkins 11th in first ‘U.S. News’ Best Global University rankings – Hub
Johns Hopkins University is the 11th best university in the world, according to the first ever Best Global University rankings published by U.S. News…
Read More
The Daily Pennsylvanian :: Penn, Drexel follow parallel paths in pushing for innovation
As Penn prepares for the ceremonial groundbreaking of the Pennovation Center on Friday, Drexel University’s Innovation Neighborhood is still searching for a master developer.…
Read More
SOSVentures Takes On Y Combinator With A Pure Biotech Accelerator – TechCrunch
International VC firm SOSVentures is capitalizing on the now buzz worthy biotech investment trend with the creation of IndieBio, the first accelerator to focus…
Read More
In biotech’s boardrooms, there are 10 men for every one woman, report says – FierceBiotech
The average board of directors in the biotech world is roughly 90% male, according to a new analysis, and more than half of all…
Read More
Strand Life Sciences to Demonstrate New StrandOmics Features at AMP 2014 Annual Meeting
Strand Life Sciences (Strand) representatives will demonstrate new capabilities of the company's variant interpretation and reporting software, StrandOmics at the Association For Molecular Pathologist…
Read More
Advent Life Sciences Raises £145.5M (USD 235M) for its Second Life Sciences Venture Capital Fund
Advent Life Sciences today announced the closing of Advent Life Sciences Fund II (ALSF II), a £145.5M (USD 235M) venture capital fund raised to…
Read More
NHLBI Funding & Research Opportunities and Announcements for October 28, 2014
Funding and Research Opportunities The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of…
Read More
Bio Venture Specialists Advent Raise $235M For European, U.S. Deals – Xconomy
Another early-stage biotech investor has clocked in with a new fund. London-based Advent Life Sciences said Tuesday it has closed a $235 million vehicle,…
Read More
Paragon Bioservices Raises $13 Million in Financing, Led by NewSpring Capital and Camden Partners
Paragon Bioservices, Inc. ("Paragon"), a privately held contract research and manufacturing organization whose mission is to accelerate the development and manufacturing of biopharmaceuticals and…
Read More